Craig is Professor of Surgery at the University of Virginia and Director of the Human Immune Therapy Center, which he founded to bridge laboratory discoveries with clinical applications. An internationally recognized expert in melanoma immunology and cancer vaccine development, his research focuses on developing and optimizing melanoma vaccines, often in combination with immune modulators. Craig has maintained continuous NIH/NCI and DOD funding since 1992, holds 11 active IND applications with the FDA, and has licensed patents for immunotherapy innovations. He is also an active member of the Melanoma Committee of the Eastern Cooperative Oncology Group and a mentor to emerging physician scientists.